In a recent government meeting, Jeff from Net Recovery presented a groundbreaking medical device aimed at aiding individuals struggling with opioid addiction. This device, cleared by the FDA, offers a new alternative for those seeking to overcome their dependency without resorting to traditional methods such as methadone or Suboxone, both of which can be addictive themselves.

The device, roughly the size of a cell phone, utilizes micro electrical pulses to stimulate the brain's pleasure center, helping to alleviate withdrawal symptoms and reduce cravings. Jeff highlighted the alarming statistic that 60% of individuals in rehab in Kentucky drop out within four days due to severe withdrawal symptoms. By using this device, patients can experience a reduction in discomfort, allowing them to remain in treatment and focus on addressing the underlying issues related to their addiction.

Currently, the device is only available through private pay, as it has not yet been approved by Medicaid—a process that could take up to two years. Jeff emphasized the urgency of seeking funding, particularly from opioid settlement funds, to provide access to those in need, as the majority of potential users are typically reliant on Medicaid.

The partnership with organizations like Isaiah House, which offers comprehensive support services, is crucial. Jeff noted that while these programs are effective in addressing various life challenges faced by individuals in recovery, they do not tackle drug cravings or withdrawal symptoms. The combination of the Net Recovery device and supportive programming is showing promising results in improving treatment outcomes for those battling addiction.

As the company continues to navigate the approval process and seek funding, the hope is to expand access to this innovative treatment, ultimately helping more individuals reclaim their lives from the grips of opioid addiction.